All the participants have concomitant use of medications, including acetylcholinesterase inhibitors (donepezil or rivastigmine) and/or the N-methyl-d-aspartate receptor antagonist memantine as their standard treatment for AD. This evidence concerns the gene ACHE and Alzheimer disease.